Yu, Chunrong

Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. [electronic resource] - Cancer research Jan 2002 - 188-99 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0008-5472


Activating Transcription Factor 1
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Benzamides--pharmacology
CDC2 Protein Kinase--metabolism
Cyclic AMP Response Element-Binding Protein--metabolism
DNA-Binding Proteins--metabolism
Down-Regulation--drug effects
Drug Synergism
Enzyme Inhibitors--pharmacology
Fusion Proteins, bcr-abl--biosynthesis
G1 Phase--drug effects
HL-60 Cells--drug effects
Humans
Imatinib Mesylate
JNK Mitogen-Activated Protein Kinases
K562 Cells--drug effects
MAP Kinase Kinase 1
MAP Kinase Kinase 2
MAP Kinase Kinase Kinases--antagonists & inhibitors
MAP Kinase Signaling System--drug effects
Milk Proteins
Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors
Mitogen-Activated Protein Kinases--antagonists & inhibitors
Phosphorylation--drug effects
Piperazines--pharmacology
Protein Serine-Threonine Kinases--antagonists & inhibitors
Protein-Tyrosine Kinases--antagonists & inhibitors
Pyrimidines--pharmacology
Resting Phase, Cell Cycle--drug effects
STAT5 Transcription Factor
Trans-Activators--metabolism
Transcription Factors
U937 Cells--drug effects